Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Hippocampus ; 16(6): 541-50, 2006.
Article in English | MEDLINE | ID: mdl-16634077

ABSTRACT

Traumatic brain injury (TBI) is a significant health issue that often causes enduring cognitive deficits, in particular memory dysfunction. The hippocampus, a structure crucial in learning and memory, is frequently damaged during TBI. Since long-term potentiation (LTP) is the leading cellular model underlying learning and memory, this study was undertaken to examine how injury affects area CA1 LTP in mice using lateral fluid percussion injury (FPI). Brain slices derived from FPI animals demonstrated an inability to induce LTP in area CA1 7 days postinjury. However, area CA1 long-term depression could be induced in neurons 7 days postinjury, demonstrating that some forms of synaptic plasticity can still be elicited. Using a multi-disciplined approach, potential mechanisms underlying the inability to induce and maintain area CA1 LTP were investigated. This study demonstrates that injury leads to significantly smaller N-methyl-D-aspartate potentials and glutamate-induced excitatory currents, increased dendritic spine size, and decreased expression of alpha-calcium calmodulin kinase II. These findings may underlie the injury-induced lack of LTP and thus, contribute to cognitive impairments often associated with TBI. Furthermore, these results provide attractive sites for potential therapeutic intervention directed toward alleviating the devastating consequences of human TBI.


Subject(s)
Brain Injuries/complications , Brain Injuries/physiopathology , Hippocampus/physiopathology , Long-Term Potentiation , Memory Disorders/etiology , Memory Disorders/physiopathology , Animals , Brain Injuries/metabolism , Calcium-Calmodulin-Dependent Protein Kinase Type 2 , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Dendritic Spines/drug effects , Dendritic Spines/metabolism , Dendritic Spines/ultrastructure , Disease Models, Animal , Excitatory Postsynaptic Potentials/drug effects , Glutamic Acid/metabolism , Glutamic Acid/pharmacology , Hippocampus/metabolism , Long-Term Synaptic Depression , Memory Disorders/metabolism , Mice , Mice, Inbred C57BL , Neural Pathways/metabolism , Neural Pathways/physiopathology , Organ Culture Techniques , Receptors, N-Methyl-D-Aspartate/drug effects , Receptors, N-Methyl-D-Aspartate/metabolism , Synaptic Transmission
2.
Cell Death Differ ; 8(12): 1169-81, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11753565

ABSTRACT

In this study we examine the in vivo formation of the Apaf-1/cytochrome c complex and activation of caspase-9 following limbic seizures in the rat. Seizures were elicited by unilateral intraamygdala microinjection of kainic acid to induce death of CA3 neurons within the hippocampus of the rat. Apaf-1 was found to interact with cytochrome c within the injured hippocampus 0-24 h following seizures by co-immunoprecipitation analysis and immunohistochemistry demonstrated Apaf-1/cytochrome c co-localization. Cleavage of caspase-9 was detected approximately 4 h following seizure cessation within ipsilateral hippocampus and was accompanied by increased cleavage of the substrate Leu-Glu-His-Asp-p-nitroanilide (LEHDpNA) and subsequent strong caspase-9 immunoreactivity within neurons exhibiting DNA fragmentation. Finally, intracerebral infusion of z-LEHD-fluoromethyl ketone increased numbers of surviving CA3 neurons. These data suggest seizures induce formation of the Apaf-1/cytochrome c complex prior to caspase-9 activation and caspase-9 may be a potential therapeutic target in the treatment of brain injury associated with seizures.


Subject(s)
Caspases/metabolism , Cell Death , Cytochrome c Group/chemistry , Neurons/metabolism , Neurons/pathology , Proteins/chemistry , Seizures/metabolism , Animals , Apoptotic Protease-Activating Factor 1 , Brain/metabolism , Caspase 9 , Cytochrome c Group/metabolism , DNA Fragmentation , Enzyme Activation , Immunohistochemistry , Macromolecular Substances , Oligopeptides/metabolism , Oligopeptides/pharmacology , Proteins/metabolism , Rats , Seizures/chemically induced , Seizures/pathology
3.
Neurobiol Dis ; 8(4): 568-80, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11493022

ABSTRACT

The mechanism by which seizures induce neuronal death is not completely understood. Caspase-8 is a key initiator of apoptosis via extrinsic, death receptor-mediated pathways; we therefore investigated its role in mediating seizure-induced neuronal death evoked by unilateral kainic acid injection into the amygdala of the rat, terminated after 40 min by diazepam. We demonstrate that cleaved (p18) caspase-8 was detectable immediately following seizure termination coincident with an increase in cleavage of the substrate Ile-Glu-Thr-Asp (IETD)-p-nitroanilide and the appearance of cleaved (p15) Bid. Expression of Fas and FADD, components of death receptor signaling, was increased following seizures. In vivo intracerebroventricular z-IETD-fluoromethyl ketone administration significantly reduced seizure-induced activities of caspases 8, 9, and 3 as well as reducing Bid and caspase-9 cleavage, cytochrome c release, DNA fragmentation, and neuronal death. These data suggest that intervention in caspase-8 and/or death receptor signaling may confer protection on the brain from the injurious effects of seizures.


Subject(s)
Adaptor Proteins, Signal Transducing , Amygdala/pathology , Apoptosis/physiology , Carrier Proteins/metabolism , Caspases/metabolism , Epilepsy/pathology , Neurons/pathology , Amygdala/metabolism , Animals , BH3 Interacting Domain Death Agonist Protein , Carrier Proteins/analysis , Carrier Proteins/biosynthesis , Caspase 3 , Caspase 8 , Caspase 9 , Caspase Inhibitors , Caspases/analysis , Cysteine Proteinase Inhibitors/pharmacology , DNA Fragmentation/physiology , Electroencephalography , Enzyme Inhibitors/pharmacology , Epilepsy/chemically induced , Fas-Associated Death Domain Protein , Glioma , Immunohistochemistry , In Situ Nick-End Labeling , Male , Neurons/enzymology , Oligopeptides/pharmacology , Protein Biosynthesis , Proteins/analysis , Rats , Rats, Sprague-Dawley , Receptors, TNF-Related Apoptosis-Inducing Ligand , Receptors, Tumor Necrosis Factor/analysis , Receptors, Tumor Necrosis Factor/biosynthesis , Receptors, Tumor Necrosis Factor, Member 25 , Staurosporine/pharmacology , TNF Receptor-Associated Factor 1 , Tumor Cells, Cultured
4.
J Neurochem ; 77(3): 886-95, 2001 May.
Article in English | MEDLINE | ID: mdl-11331417

ABSTRACT

Seizure-induced neuronal death may be under the control of the caspase family of cell death proteases. We examined the role of caspase-2 in a model of focally evoked limbic seizures with continuous EEG recording. Seizures were elicited by microinjection of kainic acid into the amygdala of the rat and terminated after 40 min by diazepam. Caspase-2 was constitutively present in brain, mostly within neurons, and was detected in both cytoplasm and nucleus. Cleaved caspase-2 (12 kDa) was detected immediately following seizure termination within injured ipsilateral hippocampus, contiguous with increased Val-Asp-Val-Ala-Asp (VDVADase) activity, a putative measure of activated caspase-2. Expression of receptor interacting protein (RIP)-associated Ich-1-homologous protein with death domain (RAIDD) was increased following seizures, whereas expression of RIP and tumor necrosis factor receptor associated protein with death domain (TRADD), other components thought to be linked to the caspase-2 activation and signaling mechanism, were unchanged. Intracerebroventricular administration of z-VDVAD-fluoromethyl ketone blocked seizure-induced caspase-2 activity but did not alter caspase-8 activity and failed to affect DNA fragmentation or neuronal death. These data support activation of caspase-2 following seizures but suggest that parallel caspase pathways may circumvent deficits in caspase-2 function to complete the cell death process.


Subject(s)
Apoptosis , Caspases/metabolism , Neurons/pathology , Seizures/pathology , Amygdala/drug effects , Animals , Brain/enzymology , Brain/ultrastructure , Caspase 2 , Caspase Inhibitors , Cell Nucleus/enzymology , Cytoplasm/enzymology , DNA Fragmentation , Diazepam/pharmacology , Electroencephalography , Enzyme Activation , Enzyme Inhibitors/pharmacology , Immunohistochemistry , In Situ Nick-End Labeling , Kainic Acid/administration & dosage , Male , Microinjections , Neurons/enzymology , Neurons/ultrastructure , Rats , Rats, Sprague-Dawley , Seizures/chemically induced , Seizures/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...